82 related articles for article (PubMed ID: 25038879)
1. Cardiac glycosides and the risk of breast cancer in women with chronic heart failure and supraventricular arrhythmia.
Couraud S; Dell'Aniello S; Bouganim N; Azoulay L
Breast Cancer Res Treat; 2014 Aug; 146(3):619-26. PubMed ID: 25038879
[TBL] [Abstract][Full Text] [Related]
2. Cardiac glycosides use and the risk of lung cancer: a nested case-control study.
Couraud S; Azoulay L; Dell'Aniello S; Suissa S
BMC Cancer; 2014 Aug; 14():573. PubMed ID: 25104329
[TBL] [Abstract][Full Text] [Related]
3. Use of cardiac glycosides and risk of glioma.
Seliger C; Meier CR; Jick SS; Uhl M; Bogdahn U; Hau P; Leitzmann MF
J Neurooncol; 2016 Apr; 127(2):321-8. PubMed ID: 26721242
[TBL] [Abstract][Full Text] [Related]
4. Use of Calcium Channel Blockers and Risk of Breast Cancer: A Population-based Cohort Study.
Azoulay L; Soldera S; Yin H; Bouganim N
Epidemiology; 2016 Jul; 27(4):594-601. PubMed ID: 27031042
[TBL] [Abstract][Full Text] [Related]
5. The use of atypical antipsychotics and the risk of breast cancer.
Azoulay L; Yin H; Renoux C; Suissa S
Breast Cancer Res Treat; 2011 Sep; 129(2):541-8. PubMed ID: 21479550
[TBL] [Abstract][Full Text] [Related]
6. Concurrent use of tamoxifen with CYP2D6 inhibitors and the risk of breast cancer recurrence.
Azoulay L; Dell'Aniello S; Huiart L; du Fort GG; Suissa S
Breast Cancer Res Treat; 2011 Apr; 126(3):695-703. PubMed ID: 20848186
[TBL] [Abstract][Full Text] [Related]
7. Use of antibiotics and risk of breast cancer.
García Rodríguez LA; González-Pérez A
Am J Epidemiol; 2005 Apr; 161(7):616-9. PubMed ID: 15781950
[TBL] [Abstract][Full Text] [Related]
8. Local estrogen therapy and risk of breast cancer recurrence among hormone-treated patients: a nested case-control study.
Le Ray I; Dell'Aniello S; Bonnetain F; Azoulay L; Suissa S
Breast Cancer Res Treat; 2012 Sep; 135(2):603-9. PubMed ID: 22903687
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for hyperkalaemia in a cohort of patients with newly diagnosed heart failure: a nested case-control study in UK general practice.
Michel A; Martín-Pérez M; Ruigómez A; García Rodríguez LA
Eur J Heart Fail; 2015 Feb; 17(2):205-13. PubMed ID: 25581138
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina.
Bradbury BD; Lash TL; Kaye JA; Jick SS
Cancer; 2005 Mar; 103(6):1114-21. PubMed ID: 15712362
[TBL] [Abstract][Full Text] [Related]
11. Antidiabetic therapy and the risk of heart failure in type 2 diabetic patients: an independent effect or confounding by indication.
Koro CE; Bowlin SJ; Weiss SR
Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):697-703. PubMed ID: 15654719
[TBL] [Abstract][Full Text] [Related]
12. The Long-Term Effects of Organophosphates Poisoning as a Risk Factor of CVDs: A Nationwide Population-Based Cohort Study.
Hung DZ; Yang HJ; Li YF; Lin CL; Chang SY; Sung FC; Tai SC
PLoS One; 2015; 10(9):e0137632. PubMed ID: 26339906
[TBL] [Abstract][Full Text] [Related]
13. Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer.
Pinder MC; Duan Z; Goodwin JS; Hortobagyi GN; Giordano SH
J Clin Oncol; 2007 Sep; 25(25):3808-15. PubMed ID: 17664460
[TBL] [Abstract][Full Text] [Related]
14. Torasemide reduces dilated cardiomyopathy, complication of arrhythmia, and progression to heart failure.
Han LN; Guo SL; Lin XM; Shi XM; Zang CB; Yang LM; Ding GL
Genet Mol Res; 2014 Sep; 13(3):7262-74. PubMed ID: 25222231
[TBL] [Abstract][Full Text] [Related]
15. The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease.
Mokhles MM; Trifirò G; Dieleman JP; Haag MD; van Soest EM; Verhamme KM; Mazzaglia G; Herings R; Luise Cd; Ross D; Brusselle G; Colao A; Haverkamp W; Schade R; Camp Gv; Zanettini R; Sturkenboom MC
Pharmacol Res; 2012 Mar; 65(3):358-64. PubMed ID: 22123498
[TBL] [Abstract][Full Text] [Related]
16. Night-shift work, sleep duration, daytime napping, and breast cancer risk.
Wang P; Ren FM; Lin Y; Su FX; Jia WH; Su XF; Tang LY; Ren ZF
Sleep Med; 2015 Apr; 16(4):462-8. PubMed ID: 25794454
[TBL] [Abstract][Full Text] [Related]
17. Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers.
Eisen A; Lubinski J; Gronwald J; Moller P; Lynch HT; Klijn J; Kim-Sing C; Neuhausen SL; Gilbert L; Ghadirian P; Manoukian S; Rennert G; Friedman E; Isaacs C; Rosen E; Rosen B; Daly M; Sun P; Narod SA;
J Natl Cancer Inst; 2008 Oct; 100(19):1361-7. PubMed ID: 18812548
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
Krajcik RA; Borofsky ND; Massardo S; Orentreich N
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
[TBL] [Abstract][Full Text] [Related]
19. Androgen deprivation therapy and risk of acute kidney injury in patients with prostate cancer.
Lapi F; Azoulay L; Niazi MT; Yin H; Benayoun S; Suissa S
JAMA; 2013 Jul; 310(3):289-96. PubMed ID: 23860987
[TBL] [Abstract][Full Text] [Related]
20. Use of diuretics and risk of incident gout: a population-based case-control study.
Bruderer S; Bodmer M; Jick SS; Meier CR
Arthritis Rheumatol; 2014 Jan; 66(1):185-96. PubMed ID: 24449584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
